News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
While actual clinical implementation remains distant, MALDI imaging technology has advanced to the point where it might feasibly be applied to pathology.
Waters has obtained a non-exclusive license to the technology, which allows researchers to create internal standard calibration curves for their assays.
Though still on the fringes of life science research, these instruments could be attractive for targeted applications due to their portability and simplicity.
The device allows more efficient delivery to mass specs of the charged droplets containing analytes of interest that are generated via electrospray ionization.
The study details the validation of the mass spec-based preterm birth test, which the company launched nationwide last month through its agreement with LabCorp.
